Skin cancer test provider Castle Biosciences prices upsized IPO at the $16 high end

July 25, 2019
In Recent news

Recent Blogs Articles

view all

How Big is the Secondary Market for Venture Capital?

By Hans Swildens, Victor Hwang, and Nick Laszlo “How big is the market?”, a question we are commonly asked due to our investments in the secondary venture market. This can be difficult to answer for a variety of reasons, the main one is confidentiality. Most sales/investments are not publicly announced. Our estimates are not only…

Read More

Read More

White Paper: Small Tech Buyout – The Fourth Exit Option

Read More